The A-CURE Faculty and network of colleagues are on the front lines of treating COVID-19 patients within hospital systems. The data on treatment and outcomes in these patients is fluid and rapidly evolving.
Current data indicate that 7-16% of COVID-19 patients experience cardiac complications or acute cardiac injury (Link to JACC paper). Further, reports indicate that mortality exceeds 10% in patients with underlying cardiovascular disease.
Worldwide, we along with our industry partners understand that some COVID-19 patients are currently being supported with mechanical circulatory support.
In this turbulent environment, there is no clear treatment modality for these patients and the open exchange of data and
experiences will be critical to optimizing patient outcomes.
To facilitate an open exchange, the A-CURE Faculty have established this website section to disseminate the rapidly evolving information available regarding patients in which mechanical support and acute ventricular unloading may be of use. We will exchange clinical data, basic research, and case studies which may help inform decision making to treat.